Atopobium Vaginae: The BV Bacteria Your Doctor Might Not Mention
You've been to the doctor. Again. You've taken the metronidazole. Again. You felt better for a few weeks maybe even a month and then, like clockwork, the symptoms came back. The discharge. The odor. The frustration of sitting in an exam room and being handed the same prescription for what feels like the hundredth time.
Here's something most women in this cycle are never told: there may be a second bacteria hiding inside your BV that your standard treatment isn't even targeting.
Its name is Atopobium vaginae recently renamed Fannyhessea vaginae by researchers and it is one of the most significant, least-discussed reasons why bacterial vaginosis keeps coming back for so many women. If your BV is recurrent, persistent, or always returns after metronidazole specifically, this bacteria deserves your full attention.
What Is Atopobium Vaginae?
Atopobium vaginae is an anaerobic bacterium meaning it thrives in low-oxygen environments that is found almost exclusively in the vaginal tract. It was first isolated from vaginal samples in the late 1990s and has since been identified as a key player in recurrent and treatment-resistant BV.
In 2020, researchers reclassified it under the name Fannyhessea vaginae, though you will still see it referred to as Atopobium vaginae in most clinical literature and conversations. For the purposes of this post, we'll use both names interchangeably so you recognize it however your doctor or your own research uses it.
In a healthy vagina dominated by Lactobacillus bacteria, Atopobium is either absent or present in extremely small numbers. It is when Lactobacillus populations decline due to hormonal changes, sexual activity, antibiotics, or other disruptions that Atopobium moves in and establishes itself.
What makes it particularly dangerous is not just that it is present in BV, but how deeply it embeds itself into the vaginal environment and how cleverly it resists elimination.
How Common Is It in BV?
Studies have found Atopobium vaginae in a striking proportion of BV cases:
Research published in the British Medical Journal (BMJ) found Atopobium present in approximately 96% of BV-positive women tested, compared to fewer than 10% of women with a healthy vaginal microbiome
A study published in Sexually Transmitted Infections found that women who tested positive for both Gardnerella vaginalis AND Atopobium vaginae had significantly higher rates of BV recurrence than women with Gardnerella alone
Atopobium has been detected even in women who tested negative for BV by standard clinical criteria (the Amsel criteria), suggesting it may be present at sub-diagnostic levels before a full BV episode develops
This means Atopobium is not a rare or minor player. It is present in the vast majority of BV cases and is a critical factor in why those cases recur.
The Biofilm Connection
To understand why Atopobium is so hard to eradicate, you have to understand its relationship with Gardnerella vaginalis and vaginal biofilm which we covered in depth in our post on biofilm and BV.
Here is the short version: Gardnerella vaginalis is the primary architect of vaginal biofilm. It adheres to the vaginal wall, multiplies, and creates a dense, protective matrix of proteins, sugars, and DNA that acts like a fortified shelter for bacterial communities.
Atopobium vaginae is one of the key bacteria that moves into that shelter and lives deep within it. Studies using fluorescence microscopy which allows researchers to visually identify specific bacteria inside biofilm have confirmed that Atopobium consistently occupies the innermost layers of Gardnerella biofilm. This is the layer that antibiotics penetrate least effectively.
This biofilm partnership between Gardnerella and Atopobium is a significant reason why:
BV symptoms return so quickly after treatment
Metronidazole, in particular, fails to produce lasting results
Some women feel that no matter what they do, BV always comes back within the same menstrual cycle
Why Metronidazole Doesn't Work Against It
This is the critical piece of information that most women with recurrent BV are never given.
Atopobium vaginae is intrinsically resistant to metronidazole. This is not a case of the bacteria developing resistance over time through repeated exposure it was never susceptible to metronidazole to begin with. The drug's mechanism of action simply does not work effectively against this particular organism.
Metronidazole (sold under brand names including Flagyl and Metrozin) is the most commonly prescribed first-line treatment for BV worldwide. It works well against many of the anaerobic bacteria associated with BV, including Gardnerella at the free-floating (planktonic) level. But because it cannot reliably penetrate biofilm AND cannot kill Atopobium even when it does reach it, a significant portion of the BV community survives every metronidazole course protected and waiting.
When the treatment ends, those surviving Atopobium bacteria along with the Gardnerella embedded in the same biofilm simply continue growing and rebuilding the population. Within weeks, you're back to square one.
What About Clindamycin?
Clindamycin is a better option for Atopobium-positive BV. Unlike metronidazole, clindamycin does have activity against Atopobium vaginae, making it more effective at targeting the full bacterial community involved in recurrent BV.
This is why some gynecologists who are familiar with the role of Atopobium in recurrent BV will switch patients from metronidazole to clindamycin either the oral form or the vaginal cream when BV keeps returning.
However, clindamycin is still not a complete solution on its own. Remember that Atopobium lives deep within biofilm, and clindamycin, like all antibiotics, struggles to fully penetrate a mature biofilm structure. This is why researchers increasingly argue that biofilm disruption must be part of treatment for recurrent BV not just bacterial killing.
Agents like EDTA (which breaks down the biofilm matrix) used in combination with clindamycin represent one of the more promising directions in recurrent BV research precisely because they address both the structural biofilm and the bacteria inside it, including Atopobium.
How Is Atopobium Vaginae Detected?
Here is where another frustrating gap in standard care becomes apparent: Atopobium is not detected by routine BV testing.
The standard clinical diagnosis of BV uses the Amsel criteria a combination of four signs including discharge appearance, pH above 4.5, a positive whiff test, and the presence of clue cells under a microscope. None of these tests identify which specific bacteria are present. Atopobium can be living in high concentrations in your vaginal biofilm while your standard BV test looks completely normal.
There is also the Nugent score, a laboratory method of scoring vaginal bacteria from a Gram-stained slide. Again, this scores bacterial morphology types, not specific species so Atopobium's presence is not directly confirmed.
To specifically detect Atopobium vaginae, you need molecular testing (PCR-based testing) that targets its specific DNA. This type of testing is available through some specialty labs and is increasingly included in advanced vaginal microbiome panel tests, such as:
Juno Diagnostics vaginal microbiome testing
Evvy vaginal microbiome test (at-home swab with PCR analysis)
Specialty women's health clinics offering comprehensive vaginal panel testing
If you have recurrent BV especially recurrence after multiple metronidazole courses it is worth asking your provider about molecular/PCR-based vaginal testing to determine whether Atopobium is part of your bacterial picture. This information can meaningfully change your treatment plan.
Atopobium and Pregnancy
Atopobium vaginae during pregnancy is an area of particular concern. Research has linked the presence of Atopobium in the vaginal tract during pregnancy to:
Preterm labor and premature rupture of membranes (PROM)
Late miscarriage (second trimester pregnancy loss)
Chorioamnionitis (infection of the amniotic membranes)
Low birth weight
A study published in the American Journal of Obstetrics and Gynecology found that women who tested positive for Atopobium vaginae during pregnancy had significantly elevated risks of preterm birth compared to women without it even when standard BV criteria were not fully met.
This is particularly alarming given that standard BV testing during pregnancy would likely miss a standalone Atopobium presence. If you are pregnant, have a history of recurrent BV, or have experienced pregnancy complications in the past, discussing PCR-based vaginal testing with your OB-GYN is a conversation worth having.
Atopobium, BV, and STI Risk
One additional dimension that doesn't get discussed enough: the presence of Atopobium vaginae like BV generally is associated with increased susceptibility to sexually transmitted infections, including:
HIV acquisition BV-associated bacteria including Atopobium trigger inflammation and disrupt the vaginal mucosal barrier, making HIV transmission easier
HPV persistence Studies suggest that vaginal dysbiosis with Atopobium may be linked to HPV persistence and potentially cervical cell abnormalities
Chlamydia and gonorrhea A disrupted vaginal microbiome with elevated Atopobium reduces the natural antimicrobial defenses that would otherwise inhibit these pathogens
This is not meant to cause alarm it is meant to underscore why getting recurrent BV under genuine control matters beyond just comfort and odor. Your vaginal microbiome is part of your immune defense system, and Atopobium's chronic presence undermines it.
A Smarter Treatment Approach for Atopobium-Positive Recurrent BV
If you suspect Atopobium is playing a role in your recurrent BV, here is what a more targeted approach might look like in conversation with your healthcare provider:
Request PCR-based vaginal testing to confirm Atopobium presence and get a full picture of your vaginal bacterial community
Discuss switching from metronidazole to clindamycin oral or vaginal given Atopobium's inherent metronidazole resistance
Ask about combination approaches that address biofilm alongside bacteria including EDTA-based gels, boric acid suppositories, or newer formulations like Fluomizin (dequalinium chloride)
Follow treatment with targeted probiotics specifically Lactobacillus crispatus, L. rhamnosus GR-1, and L. reuteri RC-14 to help restore protective bacterial dominance and prevent Atopobium from re-establishing
Support your vaginal pH daily pH-balanced cleansers externally, cotton underwear, no douching, and condom use to reduce repeated pH disruption
Track your cycle and triggers many women notice Atopobium driven recurrences occur specifically right after their period (when pH rises naturally) or after unprotected sex; identifying your pattern helps your provider time treatment and maintenance more effectively
When to Push for More Answers
You should advocate for yourself and ask for more thorough investigation if:
You have had three or more BV episodes in one year
BV returns within four weeks of completing a full antibiotic course
Metronidazole specifically never seems to work long-term for you
You are pregnant and have a history of recurrent BV or pregnancy complications
You have been told your tests are "normal" but you continue to have symptoms
You are not imagining it. You are not "just prone to BV." In many of these cases, there is a specific, identifiable bacterial reason and Atopobium vaginae is one of the most likely culprits that standard testing and treatment completely miss.
Frequently Asked Questions
Is Atopobium vaginae an STI?
No. Atopobium vaginae is not classified as a sexually transmitted infection. However, it can be influenced by sexual activity, and there is some evidence suggesting it may be shared between partners. It is considered a commensal organism that becomes problematic when it overgrows in the context of vaginal dysbiosis.
Can I treat Atopobium naturally?
There are no natural treatments with proven efficacy specifically against Atopobium vaginae. Boric acid and probiotics may help support the overall vaginal environment and reduce recurrence risk, but they are not substitutes for proper medical treatment in active infections.
Will my Atopobium ever go away completely?
Yes with the right treatment approach targeting both the bacteria and the biofilm it lives in, long-term remission is absolutely possible. It requires a more intentional plan than a standard BV prescription, but many women do achieve lasting results.
Does my partner need treatment too?
Current guidelines do not routinely recommend partner treatment for BV. However, some researchers argue that in cases of recurrent BV with confirmed Atopobium, partner bacterial transmission may be a factor worth discussing with your provider especially if you are in a sexual relationship with a male partner.
“This article is based on current medical guidance and research from the following trusted sources:”
Resources & Sources
Ferris, M.J., et al. (2004).- Association of Atopobium vaginae with bacterial vaginosis. BMC Infectious Diseases.
Bradshaw, C.S., et al. (2006).- High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy. Journal of Infectious Diseases.
Muzny, C.A., & Schwebke, J.R. (2015).- Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections. Clinical Infectious Diseases.
Swidsinski, A., et al. (2008). -Spatial organization of the Gardnerella biofilm. FEMS Immunology & Medical Microbiology.
National Institutes of Health (NIH) PubMed: pubmed.ncbi.nlm.nih.gov
Centers for Disease Control and Prevention (CDC)- BV Fact Sheet: cdc.gov/std/bv
American College of Obstetricians and Gynecologists (ACOG): acog.org
Has your doctor ever mentioned Atopobium or suggested testing beyond a standard BV swab? Share your experience in the comments your story could be exactly what another woman needs to hear to finally ask the right questions at her next appointment.
Author
Becky Freeman is the founder of BVTalks®. She focuses on women’s intimate health, vaginal microbiome education, and creating practical, easy-to-understand content for everyday care.
Disclaimer: This post is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider for diagnosis and treatment.
